| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An exploratory factor analysis of the spontaneous reporting of severe cutaneous adverse reactions
|
Hauben, Manfred
|
|
2017
|
|
1 |
p. 4-16
|
artikel
|
| 2 |
Incident adverse drug reactions in geriatric inpatients: a multicentred observational study
|
Lavan, Amanda
|
|
2018
|
|
1 |
p. 13-23
|
artikel
|
| 3 |
Ivabradine: a new rate-limiting therapy for coronary artery disease and heart failure
|
Rushworth, Gordon F.
|
|
2011
|
|
1 |
p. 19-28
|
artikel
|
| 4 |
Latest drug safety alerts from the 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management
|
Mallarkey, Gordon
|
|
2012
|
|
1 |
p. 5-11
|
artikel
|
| 5 |
Management of hyponatraemia in older people: old threats and new opportunities
|
Soiza, Roy L.
|
|
2011
|
|
1 |
p. 9-17
|
artikel
|
| 6 |
Methodological challenges in using routinely collected health data to investigate long-term effects of medication use during pregnancy
|
Grzeskowiak, Luke E.
|
|
2013
|
|
1 |
p. 27-37
|
artikel
|
| 7 |
Naloxone dosage for opioid reversal: current evidence and clinical implications
|
Rzasa Lynn, Rachael
|
|
2018
|
|
1 |
p. 63-88
|
artikel
|
| 8 |
New antiepileptic medication linked to blue discoloration of the skin and eyes
|
Clark, Sarah
|
|
2015
|
|
1 |
p. 15-19
|
artikel
|
| 9 |
Opposing conclusions from post hoc analyses of the AFFIRM trial: was propensity score analysis to blame or just an innocent victim?
|
Woodman, Richard J.
|
|
2014
|
|
1 |
p. 4-7
|
artikel
|
| 10 |
Patterns of serum laboratory monitoring for safety and efficacy in patients on chronic statin therapy
|
Lowe, Rachel N.
|
|
2013
|
|
1 |
p. 9-17
|
artikel
|
| 11 |
Poly-de-prescribing to treat polypharmacy: efficacy and safety
|
Garfinkel, Doron
|
|
2018
|
|
1 |
p. 25-43
|
artikel
|
| 12 |
Polypharmacy and inappropriate medication use in patients with dementia: an underresearched problem
|
Parsons, Carole
|
|
2017
|
|
1 |
p. 31-46
|
artikel
|
| 13 |
Precision medicine: does ethnicity information complement genotype-based prescribing decisions?
|
Shah, Rashmi R.
|
|
2018
|
|
1 |
p. 45-62
|
artikel
|
| 14 |
Predicting risk of adverse drug reactions in older adults
|
Lavan, Amanda Hanora
|
|
2016
|
|
1 |
p. 11-22
|
artikel
|
| 15 |
Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain
|
Toth, Cory
|
|
2014
|
|
1 |
p. 38-56
|
artikel
|
| 16 |
Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access
|
Wermeling, Daniel P.
|
|
2015
|
|
1 |
p. 20-31
|
artikel
|
| 17 |
Risk of acute urinary retention associated with inhaled anticholinergics in patients with chronic obstructive lung disease: systematic review
|
Loke, Yoon K.
|
|
2013
|
|
1 |
p. 19-26
|
artikel
|
| 18 |
Risk of intracranial hypertension with intrauterine levonorgestrel
|
Friedman, Deborah
|
|
2016
|
|
1 |
p. 23-24
|
artikel
|
| 19 |
Risk of intracranial hypertension with intrauterine levonorgestrel: reply
|
Etminan, Mahyar
|
|
2016
|
|
1 |
p. 25-26
|
artikel
|
| 20 |
Safety of new oral anticoagulant drugs: a perspective
|
Vílchez, Juan Antonio
|
|
2014
|
|
1 |
p. 8-20
|
artikel
|
| 21 |
Safe use of antithrombotics for stroke prevention in atrial fibrillation: consideration of risk assessment tools to support decision-making
|
Wang, Yishen
|
|
2014
|
|
1 |
p. 21-37
|
artikel
|
| 22 |
Severe haematuria of lower urinary tract origin with low dose dabigatran use in three Indian elderly patients: unresolved issues in the safety of novel oral anticoagulants
|
Kaur, Upinder
|
|
2018
|
|
1 |
p. 89-91
|
artikel
|
| 23 |
Specific features of medicines safety and pharmacovigilance in Africa
|
Isah, Ambrose O.
|
|
2012
|
|
1 |
p. 25-34
|
artikel
|
| 24 |
Spontaneously reported haemorrhagic adverse events associated with rivaroxaban and dabigatran in Australia
|
Chen, Esa Y. H.
|
|
2016
|
|
1 |
p. 4-10
|
artikel
|
| 25 |
Statins and their interactions with other lipid-modifying medications: safety issues in the elderly
|
Ho, Clement K.M.
|
|
2012
|
|
1 |
p. 35-46
|
artikel
|
| 26 |
Targeting precision medicine toxicity: recent developments
|
Mallarkey, Gordon
|
|
2015
|
|
1 |
p. 4-14
|
artikel
|
| 27 |
The ABCD of clinical pharmacokinetics
|
Doogue, Matthew P.
|
|
2013
|
|
1 |
p. 5-7
|
artikel
|
| 28 |
The hope, hype and reality of Big Data for pharmacovigilance
|
Bate, Andrew
|
|
2018
|
|
1 |
p. 5-11
|
artikel
|
| 29 |
Tiotropium formulations and safety: a network meta-analysis
|
Cazzola, Mario
|
|
2017
|
|
1 |
p. 17-30
|
artikel
|
| 30 |
Value of preapproval safety data in predicting postapproval hepatic safety and assessing the legitimacy of class warning
|
Lin, Yeong-Liang
|
|
2012
|
|
1 |
p. 13-24
|
artikel
|
| 31 |
Who should support the costs of severe adverse drug reactions?
|
Roujeau, Jean-Claude
|
|
2011
|
|
1 |
p. 5-8
|
artikel
|
Tijdschrift beschrijving